Medscape Alerts
Medscape Alerts
- Alert FDA: Antidepressant Labels Must Warn of Suicidality Risk in Young Adults
- Alert Cardiovascular Risks of Haloperidol Highlighted
- Alert FDA Reviewing Proton-Pump Inhibitor Safety
- Alert Globus Media Home Medical Tests Illegal, Untested, and May Be Inaccurate
- Alert FDA Recalls Mizuho Surgical Tables
- Alert TNF Blockers and Cancer: FDA Requires Increased Surveillance
- Alert FDA Provides Update on Drospirenone VTE Risk
- Alert Sepsis Drug Xigris Pulled From Worldwide Market
- Alert FDA Update for Neuropsychiatric Events With Varenicline
- Alert Do Not Give Flu Vaccine by Jet Injection, FDA Says
- Alert Protelos and Osseor Under Review by EMA
- Alert Advagraf 0.5-mg Capsules Recalled by EMA
- Alert FDA Updates Warnings on Methylene Blue, Linezolid, and Serotonergics
- Alert Dasatinib May Raise Risk for Pulmonary Arterial Hypertension
- Alert FDA Still 'Concerned' About Drospirenone VTE Risk
- Alert Qualitest Oral Contraceptives Recalled
- Alert Class I Recall of Certain Medtronic Infusion Pumps
- Alert DEA Moves to Make 'Bath Salts' Illegal as Overdoses Rise
- Alert TNF Blockers Get Boxed Warning on 2 Bacterial Infections
- Alert FDA Strengthens Kidney Risk Warning for Reclast